Product Description
Mechanisms of Action: Bile Acid Analogue
Novel Mechanism: Yes
Modality: Nondrug
Route of Administration: Intravenous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Norgine
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Liver Cirrhosis
Phase 2: Non-alcoholic Steatohepatitis|Hepatitis, Alcoholic|Liver Diseases, Alcoholic|Fatty Liver, Alcoholic|Hepatitis A|Liver Cirrhosis, Alcoholic
Phase 1: Liver Cirrhosis|Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
2008-003547-36 |
NRL972 in chronic heptatitis | N/A |
Completed |
Hepatitis B, Chronic |
2011-09-30 |
2022-03-12 |
Treatments |
|
NCT01164332 |
NRL972-01/2010 (AMET) | P1 |
Completed |
Liver Cirrhosis |
2010-11-01 |
2019-03-19 |
Treatments |
|
NCT00896597 |
NRL972-11/2008 (PAIR) | P1 |
Completed |
Liver Cirrhosis |
2009-12-01 |
2019-03-18 |
Treatments |
|
NCT00856713 |
NRL972-01/2005 (ACPS) | P1 |
Completed |
Liver Cirrhosis |
2006-08-01 |
2019-03-18 |
Treatments |
|
NCT00857480 |
NRL972-05/2005 (IN-B) | P1 |
Completed |
Liver Cirrhosis |
2006-08-01 |
2019-03-18 |
||
NCT00856752 |
NRL972-04A/2005 (IN-A) | P1 |
Completed |
Healthy Volunteers |
2006-07-01 |
2019-03-18 |
Treatments |
|
2007-004663-22 |
NRL972 in patients attempting alcohol cessation | P2 |
Completed |
Unknown |
2011-01-21 |
2022-03-12 |
Treatments |
|
NCT00794716 |
NRL972-01/2007 (FLD) | P2 |
Completed |
Hepatitis, Alcoholic|Fatty Liver, Alcoholic|Liver Diseases, Alcoholic|Non-alcoholic Steatohepatitis |
2010-03-01 |
2019-03-18 |
Treatments |
|
NCT00915057 |
NRL972-09/2008 (CHBC) | P2 |
Completed |
Hepatitis A |
2009-03-01 |
2019-03-18 |
Treatments |
|
NCT00856869 |
NRL972-02/2003(ACPS) | P2 |
Completed |
Non-alcoholic Steatohepatitis|Fatty Liver, Alcoholic|Hepatitis, Alcoholic|Liver Cirrhosis, Alcoholic |
2005-02-01 |
2019-03-18 |
||
2007-002404-18 |
NRL972 in hepatic cirrhosis | P3 |
Completed |
Liver Cirrhosis |
2009-06-30 |
2022-03-12 |
Treatments |
|
NCT00794482 |
NRL972-03/2006 (CIR) | P3 |
Completed |
Liver Cirrhosis |
2009-06-01 |
2019-03-18 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|